Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Frequency of Occult Restriction With Change to GLI-global Reference Equations
Lee, A.S., Zhang, Z., Helgeson, Scott A. , Lim, Kaiser G.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2661-A2661

10.1164/ajrccm.2025.211.abstracts.a2661 Get It

Abstract Rationale Pulmonary function tests (PFT) are interpreted in the context of reference values that were based on sex, age, height and previously race/ethnicity. The Global Lung Function Initiative (GLI) published spirometry references equations in 2012 and static lung volume reference equations in 2021. In 2023, the American Thoracic Society recommended removal of race from predictive equations for spirometry using the new race-neutral GLI-Global reference equations. Since the change of spirometry reference equations, we have noticed an increase in number of patients with normal spirometry but a low total lung capacity (TLC), where historically the incidence was less than 5 percent and normal spirometry was used to exclude restriction. The goal of this study was to further investigate this observation and characterize the population of patients with normal spirometry and reduced TLC, which we termed occult restriction. Methods We analyzed our existing PFT database which included 28,415 spirometry tests performed at Mayo Clinic Rochester and Mayo Clinic Florida between 2013 to 2016. 26,856 tests included lung volume measurements. The spirometry was interpreted using both GLI-2012 and GLI-Global reference equations and TLC was interpreted using GLI lung volume reference equations. Patients’ demographics including self-identified race were obtained. Patients with occult restriction were further characterized using descriptive statistics. All data analysis was done using BlueSky Statistics Version 10.3.1. Results Our study showed that 920 (3.4%) patients with normal spirometry using GLI-2012 reference equations had low TLC, while 1526 (5.7%) patients with normal spirometry using GLI-Global reference equations had low TLC. Among these patients, 697 patients had a change from abnormal to normal spirometry interpretation and 91 patients had a change from normal to abnormal spirometry interpretation when using GLI-Global reference equations. Comparing patients of different races and ethnicities, there is increased incidence of occult restriction in Caucasian patients with transition to GLI-Global, while the incidence of occult restriction decreased in African American patients. Patients who identify as African American or Southeast Asian are more likely to have occult restriction than others (Table 1). Conclusions With the change from GLI-2012 to GLI-Global spirometry reference equations, the frequency of occult restriction has increased from 3.4% to 5.7% with predominant effect on Caucasian patients. The clinical implication of this finding requires further study but clinicians need to be vigilant that a normal spirometry may not exclude restrictive lung disease using our current reference equations.
Mitochondria Are Functionally Heterogeneous Within Human Airway Smooth Muscle Cells
Bhat, Sanjana Mahadev , Sieck, Gary C.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2561-A2561

10.1164/ajrccm.2025.211.abstracts.a2561 Get It

Abstract RATIONALE: Mitochondria show cell and context-specific heterogeneity in their morphometry, determined by regulators of mitochondrial dynamics. Previously, we reported that TNFα increased maximum O2 consumption rate (OCR) and mitochondrial volume density (MVD) in human airway smooth muscle (hASM) cells. However, when normalized to mitochondrial volume, maximum OCR per mitochondrion was reduced following TNFα exposure. TNFα exposure also altered mitochondrial distribution and motility within hASM cells relative to the nuclear membrane. Although high-resolution respirometry is a valuable tool for assessing mitochondrial function, it does not account for the presence of mitochondrial structural and functional heterogeneity within cells. Therefore, a direct measurement of cellular mitochondrial function provides valuable novel information and physiological insight. Previously, we developed a confocal-based quantitative histochemical technique to determine the maximum velocity of the succinate dehydrogenase (SDH) reaction (SDHmax) in single cells and observed that cellular SDHmax corresponds with MVD. Therefore, we hypothesize that SDH activity varies relative to the intracellular mitochondrial distribution within hASM cells. METHODS: Cells were dissociated from bronchiolar tissue samples collected from female and male patients with no history of smoking or respiratory disease. Isolated hASM cells were serum-deprived for 48 h and split into two treatment groups: 1) TNFα-treated (20 ng/mL, 6 h and 24 h) and 2) time-matched untreated control. Following treatments, CellLight GFP-labeled mitochondria were imaged in 3D (Z optical slice of 0.5 μm) on a Nikon Eclipse A1 laser scanning confocal system (oil-immersion ×60/1.4 NA objective). Using a concentric shell method for analysis, MVD, mitochondrial complexity index (MCI) and SDHmax were quantified relative to the nuclear membrane. SDHmax was measured using a solution containing 80 mM succinate (maximum substrate concentration) and 1.5 mM nitroblue tetrazolium (reaction indicator). As the reaction proceeded, the change in optical density (OD), was measured every 15 s over a 10-min period. Using the Beer-Lambert equation, the change in OD was used to determine SDHmax expressed as mmol fumarate/L cell/min. RESULTS: Within each shell, SDHmax and MVD peaked in the perinuclear region and decreased toward the distal compartments of the cell in all treatment groups. When normalized to mitochondrial volume, SDHmax decreased in the perinuclear region compared to the distal compartments of the cell. Compared to control, TNFα exposure caused a significant shift in mitochondrial morphometry and function relative to the nuclear membrane. CONCLUSIONS: In summary, our data indicate that mitochondria within individual cells are morphologically heterogeneous with distinct functional properties, which is disrupted in disease.
Dysregulated Iron Metabolism in Airways of Aging Asthmatic Humans
Pfeffer-Kleemann, D.A., Ngassie, Maunick Lefin Koloko , Pfeffer-Kleemann, D, Hamrick, Samantha K. , Pabelick, Christina M. , Prakash, Y. S.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2557-A2557

10.1164/ajrccm.2025.211.abstracts.a2557 Get It

Abstract Rationale: With an increasing elderly population, understanding mechanisms that contribute to structural and functional changes in aging lung is important in the context of healthy aging and diseases such as asthma and pulmonary fibrosis that disproportionately affect the elderly. Asthma in the elderly (AIE) is a particular challenge, with thickened fibrotic bronchial airways (remodeling) and inflammation compared to non-asthmatic elderly: issues not addressed by current therapies. Factors such as iron regulation that are critical for normal physiology can become dysregulated in disease. Iron overload can catalyze a Fenton reaction that increases ROS which oxidizes lipids and proteins, i.e. iron-mediated lipid peroxidation cell death (ferroptosis).The goal of this study was to determine iron regulation in aging- and AIE-associated in human ASM (hASM), a cell type important in airway contractility and remodeling. Methods: hASM cells and lung tissues from young (<45y), and aged (>65y) male/female patients with/without asthma were used (approved by Mayo IRB #16-009655). Cells were treated with ferroptosis inhibitor deferoxamine (DFO) [100µM], inducer RSL3 [125 nM] or vehicle (DMSO) for 24 hrs. Levels of intracellular iron (Fe2+) were determined using FerroOrange. Cell lysates were examined for iron accumulation and ferroptosis markers (4-HNE, FTH1, TfR1, SLC7A11, and KEAP1), cell proliferation, and ECM production (COL1A1 and FN1), and supernatants analyzed for proinflammatory mediators IL-6 and IL-8. Results: Non-asthmatic and asthmatic elderly hASM cells showed a higher cytosolic Fe2+ and lower end-product of lipid peroxidation (4-HNE), higher level of SLC7A11 and KEAP1 (regulators of redox systems) compared to cells from young individuals. High level of iron storage (FTH1) was observed in asthmatics compared to non-asthmatic elderly, but no difference was observed for iron transporters (TfR1). Furthermore, COL1A1 and FN1 were higher in AIE hASM, compared to young hASM. COL1A1 was higher in aging hASM compared to young. DFO reduced COL1A1 in elderly, but upregulated in AIE. Cell proliferation was inhibited by DFO in aging hASM but not in young and AIE. The ferroptosis inducer RLS3 impaired antioxidant system and increased lipid peroxidation and IL-8 levels. Conclusions: Our findings suggest that iron regulation is impaired in aging and AIE hASM, resulting in iron accumulation which modulates airway remodeling via cell proliferation and ECM production. While ferroptosis per se can be targeted, it will be important to explore modulation of specific iron regulatory pathways in alleviating the impact of aging and asthma.
Targeting Airway Remodeling Via Polymer Nanoparticles
Lee, K. , Lehot, Victor , Cickek, Y.A., Prakash, Y.S., Thompson, Michael A. , Hamrick, Samantha K. , Goswami, R., Nagaraj, Harini , Rotello, Vincent M. , Pabelick, Christina M. , Prakash, Y. S.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2546-A2546

10.1164/ajrccm.2025.211.abstracts.a2546 Get It

Abstract Rationale : Airway remodeling in asthma involves increased airway smooth muscle (ASM) mass, changes to bronchial epithelial cell (BEC) layer, and increased fibrosis. ASM and BECs actively contribute by secreting growth factors and cytokines, regulating extracellular matrix (ECM) composition and enhancing cell proliferation/migration. Altering mechanisms which modulate remodeling presents a key to novel therapeutic strategies. BDNF increases ASM [Ca2+]i and contractility, and potentiates the effects of inflammation. Importantly, studies show that ASM is not only a target, but also a source of BDNF, raising the possibility of local autocrine/paracrine effects. Arginase 1 and 2 are expressed by BECs, but their roles in asthma are still under investigation with studies showing arginase 1 inhibition blunting epithelial remodeling and ASM hyperplasia. Knockdown of appealing targets such as ASM BDNF and epithelial arginases using small interfering RNA (siRNA) is a promising approach to combating inflammatory lung remodeling. Polymer based nanoparticles have been constructed which demonstrate cell-type specificity and high efficiency in delivering siRNA. Thus, we hypothesize that BDNF and arginases are central to airway remodeling and can be targeted via nanopartiacles.Methods: Primary human ASM and BEC cells from non-asthmatic vs. asthmatic individuals were obtained post-surgery from lung tissues after approval Mayo Clinic IRB. PONI-Guan NP were generated using block copolymer engineering. PCR, immunoblotting and ELISA were performed using standard techniques. Contractility studies were conducted in adult mouse precision cut lung slices. In vivo lung function studies were conducted in 6-8 week old mice, with or without mixed allergen (MA) treatment and Scireq Flexivent system. Results: PONI-Guan NP uptake demonstrates cell-type specificity in BEC/ASM co-culture and mouse lung. Arginase I/II and ECM expression is upregulated in BECs when exposed to BDNF and cytokines. In ASM, BDNF is increased in asthmatics compared to non-asthmatic controls; ECM expression is increased in response to BDNF and TNF-α. In BEC, PONI-Guan NP/siRNA inhibits Arg I/II expression, even in the presence of TNF-α. In ASM, TNF-α increases in BDNF secretion and ECM deposition are blunted by NP-delivered siRNA. PCLS and mouse lung function studies show contractility to MCh: effects suppressed by NP-delivered BDNF and Arg I siRNA. Conclusions: Our studies show the importance of BDNF/Arginase pathways in airway remodeling and efficacy of PONI-based siRNA delivery vectors in blunting remodeling processes.
Kisspeptin Alters Intracellular Calcium and Contractility in Severe Th1 and Th2 Endotypes in Airway Smooth Muscle
Tesch, J., Reza, M.I., Ramakrishnan, Y. , Pabelick, C.M., Prakash, Y.S., Britt, Rodney D. , Maina, D., Pabelick, C.M., Sathish, Venkatachalem

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2541-A2541

10.1164/ajrccm.2025.211.abstracts.a2541 Get It

Abstract Rationale: Within the asthmatic lung, inflammatory signaling alters the contractile capacity of airway smooth muscle (ASM). In chronic inflammation, ASM become hypercontractile and are a key contributor toward airway hyperresponsiveness (AHR). As a heterogenous disorder, several asthmatic endotypes have been defined. A severe ASM endotype is partly defined as being glucocorticoid insensitive. We have reported the role of Kisspeptin (Kp)/KISS1R signaling in the lung in the context of airway fibrosis. In this study, KISS1R and Kp-10 were investigated for a potential interactions with intracellular calcium [Ca2+]i signaling and ASM contractility in the in vitro setting of severe asthmatic endotypes. Methods: Primary ASM were obtained from non-pathological samples from the Mayo Clinic. ASM cells were treated with inflammatory cytokines (TNFα 20 ng/ml, or IL-13 50 ng/mL)± Kp-10 (1 μM). The steroid-insensitive asthma endotype was investigated using pro-inflammatory cytokines (TNFα 20 ng/ml and IFN-γ 25 ng/mL) ± a corticosteroid (Fluticasone Propionate 100 nM). Β2-Adrenergic Receptor (β2-AR) desensitized endotypes were developed by treating cells with a β2-AR agonist (Salbutamol 1 μM) for 24 hours prior to and along with cytokine treatments (TNFα 20 ng/ml and IFN-γ 25 ng/mL or IL-13 50 ng/mL) ± Kp-10. [Ca2+]i was measured via Fura-2AM (4 μM) labeling on an Olympus Fluoview 300 microscope. Myosin light chain (MLC) phosphorylation studies were used to quantify downstream mechanics of ASM contractility. Results: KISS1R activation in IL-13 treated cells reduced [Ca2+]i in response to histamine. In contrast, TNFα treated cells were responsive to Kp-10 for acute treatments, however this effect was lost after 24 hours of Kp-10 treatment. TNFα and IFN-γ treated cells showed a robust [Ca2+]i response to histamine, and both fluticasone (∼20% reduction) and Kp-10 (∼10% reduction) alone had a minimal effect in reducing [Ca2+]i. Fluticasone and Kp-10 co-exposure significantly reduced [Ca2+]i and significantly reduced the effect of TNFα/IFN-γ (∼45% reduction). In B2-AR desensitized cells, Kp-10 exposure maintained the effect of reducing [Ca2+]i, suggesting Kp-10/KISS1R signaling works through an alternate or independent pathway. Kp-10 treatments on cytokine exposed cells reduced p-MLC in response to histamine, suggesting a role in ASM contractility. Conclusion: The increase of [Ca2+]i in inflamed cells is associated with AHR; Kp-10/KISS1R signaling showed varying efficacy in reducing [Ca2+]i within inflammatory endotypes. These results also highlight that Kp-10 acts synergistically with the current therapeutics available for asthma.
Gene Expression Deconvolution of Hair Follicle Cells Demonstrates Lung-Relevant Cell Types. The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
Buschur, Kristina L., Martorella, Molly , Garcia-Flores, Renee , Bleecker, Eugene R., Christenson, Stephanie A. , Criner, G.J., Dransfield, M.T., Hansel, Nadia N. , Meyers, Deborah A. , Oelsner, Elizabeth C. , Paine, Robert , Woodruff, Prescott G. , Oelsner, Elizabeth C , Christenson, Stephanie A , Smith, Benjamin M. , Ziosi, Marcello , Barjaktarević, Igor , Comellas, Alejandro P. , Criner, G.J., Kaner, Robert J. , Krishnan, Jerry A , Barr, R. Graham , Lappalainen, Tuuli

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2526-A2526

10.1164/ajrccm.2025.211.abstracts.a2526 Get It

Abstract Rationale. Bronchoscopy can directly assess cells in airway epithelium in participants with COPD, but it is invasive, expensive, difficult to perform at scale, and contraindicated in severe disease. Blood is much more easily available but contains only a limited subset of cell types, many of which are less relevant to lung biology. Recent advances in RNA-sequencing technology have allowed for reliable measurement of transcriptomics in a wider variety of more accessible tissues, including hair follicle cells. We collected and performed bulk RNA-seq on hair follicles as an ancillary study within the NIH-funded SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) and investigated their cell type composition to better understand the opportunities and limitations of this tissue for the study of lung disease. Methods. SPIROMICS recruited individuals with and without COPD aged 40-80 years with ≥ 20 pack-years smoking history. Participant at several sites underwent collection of approximately 10 hair follicles from the head, which were immediately frozen at -80ºC in 2018-21. mRNA in hair follicles was measured by bulk RNA-seq, and cell type deconvolution was performed using GEDIT v1.7 with the provided BlueCodeV1.0.tsv reference matrix. Cell types were collapsed into broader categories by summing the estimated cell type proportions. Results. The cell type deconvolution of the hair follicle bulk RNA-seq from 80 participants with and without COPD estimated that the tissue was largely composed of immune cells (median 36%, including B cells, T cells, neutrophils, macrophages, NK cells, and monocytes) and epithelial cell types (median 31%), with the largest subgroup of epithelial cell types identified as hair follicular keratinocytes (Figure 1). The next largest component was fibroblasts (median 9%), followed by endothelial cells (median 8%). Signals for myocytes (median 5%), melanocytes (median 5%), and chondrocytes (median 5%) were also present. Conclusion. This initial study demonstrated promising signals for a variety of lung-relevant cell types in hair follicles in SPIROMICS, including immune and epithelial cells in addition to fibroblasts and endothelial cells that are not otherwise easily accessible. Hair follicle gene expression profiling shows promise for understanding numerous facets of lung biology and disease that both complements and exceeds that of other noninvasive tissues such as blood.
Leveraging Disease Relevant Transcriptomes From TOPMed LTRC Improves Polygenic Transcriptome Risk Prediction for COPD
Hu, Xin , Ardlie, Kristin , Lange, Leslie A., Lange, Ethan M. , Meyers, D.A., Bleecker, ER, Ortega, V.E., Silverman, Edward, Wheeler, Harry E., Liu, D., Cho, M.H., Barr, R. Graham , Kim, K., Wang, Li , Khunsriraksakul, Chachrit , Lappalainen, Tuuli , Aguet, François , Rich, Stephen S. , Rotter, Jerome I. , Meyers, D.A., Moll, Matthew , Castaldi, Peter J. , Hersh, Craig P. , Wheeler, H.E., Im, Hae Kyung , Manichaikul, Ani

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2512-A2512

10.1164/ajrccm.2025.211.abstracts.a2512 Get It

Abstract RATIONALE: Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality worldwide. We previously published the polygenic transcriptome risk score (PTRS) which uses the cumulative effect of predicted gene expression to construct genetic predictors for complex diseases, and we demonstrated the value of PTRS for COPD built on Genotype-Tissue Expression (GTEx) Lung tissue with significantly improved cross-ancestry portability. However, the postmortem collection and lack of lung disease status on GTEx samples likely affect results. We hypothesized that the performance of PTRS will be improved by using disease-relevant expression quantitative trait loci (eQTLs) to construct the score. Here, we aimed to improve performance of PTRS by leveraging disease-relevant eQTLs. METHODS: We constructed two transcriptome prediction models, Elastic Net (EN) and Prediction Using Models Informed by Chromatin conformation and Epigenomics (PUMICE), using TOPMed lung RNA-seq data from the Lung Tissue Research Consortium (LTRC), which included COPD patients undergoing lung surgery. We compared their performance with two published models built on RNA-seq from GTEx Lung tissue, GTEx-EN and GTEx-PUMICE. We first integrated each of four transcriptome models with multi-ancestry GWAS of FEV1/FVC ratio (Shrine et al. 2023) to generate transcriptome-wide association study (TWAS) results, which produced trait-associated genes. Pathway analysis was then conducted on significant TWAS genes. Finally, the PTRS was computed on TWAS genes that were included in the top 20 significantly enriched pathways. We tested performance of PTRS in race-stratified analysis for moderate-to-severe and severe COPD in COPDGene. RESULTS: Our models produced more significant TWAS genes (FDR<0.05) and had more overlaps with genes identified for FEV1/FVC ratio from Shrine et al. 2023 compared to two GTEx models (Fig. A). Additionally, our models had significantly higher AUC for predicting both moderate-to-severe and severe COPD in race-stratified analysis. The mean AUC from LTRC-EN for predicting severe COPD was 0.57 and 0.55 respectively for EUR and AFA, which was significantly higher than mean AUC of 0.54 and 0.51 from GTEx-EN (Delong p-value=8.15x10-10 for EUR and 1.42x10-3 for AFA) (Fig. B). Similarly, the PTRS derived from our models produced higher Odds Ratios (OR) per standard deviation. The mean OR from LTRC-PUMICE for moderate-to-severe COPD was 1.25 and 1.18 respectively for EUR and AFA, while it was 1.17 and 1.12 from GTEx-PUMICE (Fig. C). CONCLUSIONS: Our study demonstrates the value of leveraging disease-relevant RNA-seq to construct transcriptome prediction models and their improvement on identifying lung function genes and predicting COPD across ancestries.
A Four-gene CC16-associated Transcriptomic Score and Risk for Asthma Exacerbations
Cao, Sheng , Guerra, Stefano , Zein, Joe , Christenson, S., Castro, Mario , Denlinger, Loren C. , Fahy, J.V., Gaston, B., Hastie, Annette T. , Israel, Elliot , Mauger, David T. , Wenzel, Sally E. , Woodruff, P., Meyers, Deborah A. , Bleecker, Eugene R. , Ortega, Victor E. , Fahy, John V. , Christenson, Stephanie A. , Christenson, Stephanie A , Levy, Bruce David

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2488-A2488

10.1164/ajrccm.2025.211.abstracts.a2488 Get It

Abstract Rationale: The club cell secretory protein (CC16), encoded by the SCGB1A1 gene, has an anti-inflammatory role in airways diseases, including asthma (Li, AJRCCM 2023; Voraphani, AJRCCM 2023). We hypothesize that additional pathway genes regulated or co-expressed with CC16 have cumulative effects on asthma severity outcomes by modulating airway inflammation and maintaining lung homeostasis. Methods: As published previously, four genes were downregulated in CC16 knockout experiments and correlated with CC16 levels: BPIFA1, SFTPD, LTF, and LYZ (Iannuzo, Front. Immunol 2023). We developed a four-gene biomarker score in 94 patients with asthma from the NHLBI-sponsored Severe Asthma Research Program (SARP3) who underwent research bronchoscopy for lower airway epithelial brushings, RNA isolation, and bulk RNA sequencing. We log-transformed the raw values of each transcript; obtained standardized residuals from regression models that included sex, age, and batch effects; and summed the standardized residuals of all four proteins to estimate a standardized sum score (Zhai, JACI Allergy 2024). Logistic regression models tested the four-gene score, three-gene score without LTF, and individual transcripts for associations with exacerbations during 12-month follow-up and zero-inflated negative binomial regression for number of exacerbations. Results: 30.85% percent of 94 patients experienced at least one exacerbation at the end of follow-up. The CC16-associated four-gene biomarker score showed protective effects on asthma exacerbation risk with a 54% percent reduction in exacerbation risk for every one-fold higher score (OR=0.46, 95% CI: 0.27-0.78, p =0.0040, Figure 1). Transcript expression of BPIFA1 (OR=0.87, 95% CI:0.66-1.16, p=0.337), SFTPD (OR=0.33, 95% CI:0.04-2.52, p=0.283), LYZ (OR=0.62, 95%CI:0.28-1.39, p=0.248), and LTF (OR=0.36, 95% CI:0.18-0.74, p=0.0053) all indicated protective directionality with respect to exacerbation risk. However, only LTF demonstrated a statistically significant association. When we excluded LTF, the remaining three-gene score showed a trend toward association with risk (OR=0.64, 95% CI:0.40-1.03, p=0.068) and was significantly associated with number of exacerbations (RR=0.49, 95% CI:0.26-0.95, p=0.034). Compared to LTF alone (OR=0.48, PPV=0.50, NPV=0.71, Sensitivity=0.14, AUC=0.65), the combined four-gene score (OR=0.46, PPV=0.60, NPV= 0.73, Sensitivity=0.21, AUC=0.68) showed improved predictive performance. Conclusions: We identified a CC16-associated transcriptomic predictive score for asthma exacerbations, with LTF showing the strongest effect. Although the other three genes showed individually weak and non-significant associations with exacerbations, the three gene score was significant for number of exacerbations.We demonstrate the potential of this transcriptomic score as a predictive biomarker for asthma severity-related outcomes. Further research investigating these genes and their interaction with other CC16-associated immune pathways could provide insight into therapeutic targets.
Evaluating Bronchodilator Response as an Alternative to Methacholine Challenge for Diagnosing Bronchial Hyperreactivity in Children Presenting With Unexplained Dyspnea
Puentes, G.A. Cortes, Pillai, Sandhya, Lee, Amanda Jane , Lim, Kaiser G. , Pillai, S.M.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2287-A2287

10.1164/ajrccm.2025.211.abstracts.a2287 Get It

Abstract Rationale Bronchial hyperreactivity (BHR) is a hallmark of asthma, frequently presenting as exercise-induced dyspnea in children and adolescents. Identifying BHR is essential for accurate diagnosis and management of exercise symptoms. The methacholine challenge test (MCT) is the gold standard for diagnosing BHR due to its high sensitivity in detecting airway hyperresponsiveness. However, the MCT requires specialized equipment and stringent protocols, which can limit its availability and use in some clinical settings. An alternative approach, the bronchodilator response test (BDR), is more accessible and assesses the reversibility of airway obstruction following bronchodilator administration. BDR testing is a routine component of asthma diagnostics for evaluating airflow limitation, making it a potentially useful tool for BHR assessment. However, the ability of BDR testing to reliably detect BHR in exertional dyspnea is still uncertain. Prior research has shown that BDR testing, while specific, has low sensitivity for BHR when compared to the MCT, raising questions about its standalone utility in clinical practice. The objective of this study was to evaluate the diagnostic performance of the BDR in detecting bronchial hyperreactivity in exertional dyspnea, using the MCT as the reference standard. By analyzing sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), we aimed to assess whether BDR testing could serve as a reliable alternative to MCT for diagnosing BHR. Methods We conducted a retrospective study of pediatric patients who underwent cardiopulmonary exercise testing, BDR, and MCT as part of their assessment for exertional dyspnea from July 2020 to February 2023. Patients up to 18 years of age were included. A positive BDR was defined by a 10% or greater improvement in FEV1% or FVC%, while a positive MCT was defined by a 20% reduction in FEV1%. Data are presented in a 2x2 table, with the MCT as the reference standard. Results and Conclusion In a cohort of 98 patients, 20 underwent both bronchodilator and methacholine testing. The BDR test, using MCT as the reference, showed a sensitivity of 16.7%, specificity of 87.5%, PPV of 66.7%, and NPV of 41.2%. These results suggest that, due to its low sensitivity, BDR testing alone is insufficient for BHR detection when clinical suspicion of asthma is high. The MCT remains the preferred diagnostic method, though using both tests may provide a more comprehensive evaluation of airway reactivity in children presenting with exercise symptoms.
Beyond the Numbers: Rethinking the Role of Exhaled Nitric Oxide in Diagnosing Exercise-induced Bronchoconstriction in Pediatric Dyspnea
Puentes, G.A. Cortes, Pillai, S. M., Lee, Alexander , Lim, Kaiser G. , Pillai, S.M.

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A2286-A2286

10.1164/ajrccm.2025.211.abstracts.a2286 Get It

Abstract Rationale Exertional dyspnea in children presents a complex diagnostic challenge, often requiring multiple evaluations to uncover underlying etiologies. Exercise testing is the standard for diagnosing exercise-induced bronchoconstriction (EIB) in children but requires significant resources. Fractional exhaled nitric oxide (FeNO), a marker of airway inflammation, has been proposed as an easier alternative to predict the need for exercise testing. The aim of this study is to evaluate the diagnostic utility of fractional exhaled nitric oxide (FeNO) as a non-invasive marker of bronchial hyperreactivity in pediatric patients with exertional dyspnea, by assessing its sensitivity, specificity, and predictive values in comparison to cardiopulmonary exercise testing (CPET), the gold standard for diagnosing exercise-induced bronchoconstriction (EIB). This study seeks to determine whether FeNO can reliably guide the need for CPET, potentially streamlining the diagnostic process in children with suspected EIB, while also identifying any limitations of FeNO as a standalone diagnostic tool. Methods In this retrospective study, we reviewed pediatric patients up to 18 years of age who presented with unexplained dyspnea and underwent both CPET and FeNO testing from July 2020 to February 2023. A post-exercise decline in FEV1% of ≥10% during CPET defined a positive result for EIB. For FeNO, a threshold of ≥25 parts per billion (ppb) was considered indicative of bronchial hyperreactivity. Diagnostic agreement between FeNO and CPET was analyzed using a 2x2 table, with CPET as the reference standard. Results Among 98 patients who completed CPET, the cohort had a mean age of 14 years (SD ± 2.42), mean BMI of 22.2 kg/m² (SD ± 5.25), and 71% were female. Of these, 40 patients also underwent FeNO testing. Compared to CPET, FeNO exhibited a sensitivity of 100%, a specificity of 2.6%, a positive predictive value of 5.1%, and a negative predictive value of 100% for identifying bronchial hyperreactivity in this setting. Conclusion FeNO testing shows high sensitivity but limited specificity for detecting bronchial hyperreactivity, effectively ruling out but not confirming it independently of CPET. These findings reinforce the essential role of CPET in diagnosing EIB and suggest that FeNO may serve best as an adjunctive tool, rather than a primary diagnostic measure, in evaluating children with exertional dyspnea. A limitation of this study is the reliance on a single FeNO threshold, which may not account for individual variability in bronchial inflammation responses.